1. |
Azziz R, Carmina E, Dewailly D, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome:the complete task force report[J]. Fertil Steril, 2009, 91(2):456-488.
|
2. |
González F. Inflammation in polycystic ovary syndrome:underpinning of insulin resistance and ovarian dysfunction[J]. Steroids, 2012, 77(4):300-305.
|
3. |
Kelly CC, Lyall H, Petrie JR, et al. Low grade chronic inflammation in women with polycystic ovarian syndrome[J]. J Clin Endocrinol Metab, 2001, 86(6):2453-2455.
|
4. |
Möhlig M, Spranger J, Osterhoff M, et al. The polycystic ovary syndrome per se is not associated with increased chronic inflammation[J]. Eur J Endocrinol, 2004, 150(4):525-532.
|
5. |
Rajagopalan L, Rajarathnam K, et al. Ligand selectivity and affinity of chemokine receptor CXCR1. Role of N-terminal domain[J]. J Biol Chem, 2004, 279(29):30000-30008.
|
6. |
Moser B, Clark-Lewis I, Zwahlen R, et al. Neutrophil-activating properties of the melanoma growth-stimulatory activity[J]. J Exp Med, 1990, 171(5):1797-1802.
|
7. |
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome[J]. Fertil Steril, 2004, 81(1):19-25.
|
8. |
Sachse F, Von Eiff C, Becker K, et al. Proinflammatory impact of Staphylococcus epidermidis on the nasal epithelium quantified by IL-8 and GRO-alpha responses in primary human nasal epithelial cells[J]. Int Arch Allergy Immunol, 2008, 145(1):24-32.
|
9. |
Klein AM, Anderson K, Lafreniere D, et al. Growth-related oncogene-alpha expression in human nasal polyps[J]. Otolaryngol Head Neck Surg, 2000, 123(1Pt1):85-90.
|
10. |
Lim SS, Norman RJ, Davies MJ, et al. The effect of obesity on polycystic ovary syndrome:a systematic review and meta-analysis[J]. Obes Rev, 2013, 14(2):95-109.
|
11. |
Xiong YL, Liang XY, Yang X, et al. Low-grade chronic inflammation in the peripheral blood and ovaries of women with polycystic ovarian syndrome[J]. Eur J Obstet Gynecol Reprod Biol, 2011, 159(1):148-150.
|
12. |
Deligeoroglou E, Vrachnis N, Athanasopoulos N, et al. Mediators of chronic inflammation in polycystic ovarian syndrome[J]. Gynecol Endocrinol, 2012, 28(12):974-978.
|
13. |
Boulman N, Levy Y, Leiba R, et al. Increased C-reactive protein levels in the polycystic ovary syndrome:a marker of cardiovascular disease[J]. J Clin Endocrinol Metab, 2004, 89(5):2160-2165.
|
14. |
Velija-Asimi Z. C-reactive protein in obese PCOS women and the effect of metformin therapy[J]. Bosn J Basic Med Sci, 2007, 7(1):90-93.
|
15. |
杨艳, 乔杰, 李美芝. 白细胞介素18、白细胞介素1β与多囊卵巢综合征发病的相关性研究[J]. 中国实用妇科与产科杂志, 2008, 1(1):38-40.
|
16. |
Repaci A, Gambineri A, Pasquali R. The role of low-grade inflammation in the polycystic ovary syndrome[J]. Mol Cell Endocrinol, 2011, 335(1):30-41.
|
17. |
Haghnegahdar H, Du J, Wang D, et al. The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma[J]. J Leukoc Biol. 2000, 67(1):53-62.
|
18. |
Devalaraja RM, Nanney LB, Du J, et al. Delayed wound healing in CXCR2 knockout mice[J]. J Investig Dermato, 2000, 115(2):234-244.
|
19. |
González F, Rote NS, Minium J, et al. In vitro evidence that hyperglycemia stimulates tumor necrosis factor-alpha release in obese women with polycystic ovary syndrome[J]. J Endocrinol, 2006, 188(3):521-529.
|
20. |
Vgontzas AN, Trakada G, Bixler EO, et al. Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea[J]. Metabolism, 2006, 55(8):1076-1082.
|
21. |
Amato G, Conte M, Mazziotti G, et al. Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles[J]. Obstet Gynecol, 2003, 101(6):1177-1182.
|
22. |
Walch K, Grimm C, Zeillinger P, et al. A common interleukin-6 gene promoter polymorphism influences the clinical characteristics of women with polycystic ovary syndrome[J]. Fertil Steril, 2004, 81(6):1638-1641.
|
23. |
Benson S, Janssen OE, Hahn S, et al. Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome[J]. Brain Behav Immun, 2008, 22(2):177-184.
|
24. |
Puder JJ, Varga S, Kraenzlin M, et al. Central fat excess in polycystic ovary syndrome:relation to low-grade inflammation and insulin resistance[J]. J Clin Endocrinol Metab, 2005, 90(11):6014-6021.
|
25. |
Azziz R, Carmina E, Dewailly D, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome:the complete task force report[J]. Fertil Steril, 2009, 91(2):456-488.
|